recombivax hb suspension
merck canada inc - hepatitis b surface antigen (recombinant) - suspension - 40mcg - hepatitis b surface antigen (recombinant) 40mcg - vaccines
varivax iii powder for solution
merck canada inc - varicella virus live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella virus live attenuated (oka/merck strain) 1350unit - vaccines
trimethoprim 200mg tablets
ivax pharmaceuticals uk ltd - trimethoprim - oral tablet - 200mg
ferrous sulfate 200mg tablets
ivax pharmaceuticals uk ltd - ferrous sulfate dried - oral tablet - 200mg
colchicine 500microgram tablets
ivax pharmaceuticals uk ltd - colchicine - oral tablet - 500microgram
lamotrigine 100mg tablets
ivax pharmaceuticals uk ltd - lamotrigine - oral tablet - 100mg
varivax 1350 ufp 1 vial + 1 jer disolv 0,5 ml
vivaxim vaccine
sanofi-aventis singapore pte. ltd. - hepatitis a virus (gbm strain), inactivated - suspension, sterile - 160 i.u./0.5 ml
recombivax hb
merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 10 µg/ml - suspension for injection - 10 mcg/dose - active: hepatitis b vaccine, rdna 10 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - indicated for immunisation against infection caused by all known subtypes of hepatitis b virus. should also prevent hepatitis d (caused by delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.
recombivax hb (with preservative) solution
merck canada inc - hepatitis b surface antigen (recombinant) - solution - 10mcg - hepatitis b surface antigen (recombinant) 10mcg - vaccines